Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea
NCT03059537Phase 4Completed
- Start
- Mar 2017
- Primary completion
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chenodeoxycholic acid in bile acid malabsorption (BAM). Started Mar 2017; status: completed.
02
Drugs
chenodeoxycholic acid
03
Conditions
bile acid malabsorption (BAM)
Beyond the preview
Go deeper on NCT03059537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059537.